GSK-2820151

N/A

Report date: 2025/05/13 16:53:17

NME

Base Information

Drug NameGSK-2820151

Drug Alias NameGSK-2820151I-BET-282-E

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBromodomain-containing protein 3 inhibitorsBromodomain-containing protein 2 inhibitorsBromodomain-containing protein 4 inhibitors +[4]

TargetsBromodomain-containing protein 3Bromodomain-containing protein 2Bromodomain-containing protein 4 +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A